Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Biphasic Insulin Aspart 30 vs Biphasic Human Insulin 30 in T2D
NCT01487798Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2002
- Primary completion
- Nov 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2002; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01487798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487798.